Within the surgical population admitted to intensive care units (ICUs), cancer is a common condition. However, clinicians can be reluctant to admit patients with cancer to ICUs owing to concerns about survival.
U p to 5% of patients with a solid malignant tumor are admitted to an intensive care unit (ICU) within 2 years of diagnosis, with most receiving organ support during their stay. 1 Most of these patients are admitted from a surgical specialty unit, often at the time of surgical intervention for their cancer. As the incidence of cancer continues to rise, 2 it seems likely that the number of patients with cancer who are considered for intensive care will also increase. There is some evidence that decisions to admit patients with cancer are influenced by assumptions about poor prognoses, with cancer being the second most common cause cited for ICU refusal. 3, 4 As outcomes in patients with cancer continue to improve, these assumptions may not be valid. 5 A systematic review illustrated that variations in ICU mortality among patients with cancer were largely attributable to differences between study populations' severity of illness, type of admission, performance status, and need for organ support rather than the presence of cancer. 6 A limitation of many previously published studies has been that they do not include a comparison group of patients without cancer; thus, it is difficult to determine the effect of cancer within the same ICU setting. 7 Taccone et al 8 described
the outcomes of all patients with cancer admitted to 198 European ICUs in 2002 and found that survival of patients with solid tumors was similar to that of ICU patients without cancer. More recently, a series of articles by Bos and colleagues [9] [10] [11] detailed outcomes in general ICUs for patients with cancer in the Netherlands. They found that, while unplanned surgical ICU admission was associated with similar ICU mortality in patients with and without cancer, in-hospital mortality after ICU admission was higher for surgical patients with cancer than for those without cancer, at 17.4% compared with 14.6%. 10 Considering the limited information on the comparative outcomes of patients with and without cancer admitted to general ICUs published to date, we sought to describe the characteristics and outcomes of surgical patients with solid malignant tumors following ICU admission.
Methods

Data Sources and Variables
This was a retrospective observational study of patients living in the West of Scotland region aged 16 years or older who were admitted to a general ICU located in the region between January 1, 2000, and December 31, 2011. Within the United Kingdom, ICU physicians have full admitting rights, although the ICU and surgical team share patient care. Full details are described elsewhere. 1 Patients admitted from a surgical specialty at admission to the ICU were selected based on the admitting specialty recorded in the ICU database. were made available to the research group, but the analysis for this study was performed on an anonymized data set. Ethical review concluded that no additional patient consent would be required owing to the nature of the study.
The study used 4 linked data sets: the Scottish Cancer Registry, Scottish Morbidity Record 01, national death records, and the Scottish Intensive Care Society Audit Group WardWatcher ICU database. WardWatcher collects data on patient demographics, admitting specialty, admission diagnosis, the Acute Physiology and Chronic Health Evaluation (APACHE) II scoring system, 12 and type of organ support.
Organ support was defined as receipt of invasive mechanical ventilation, vasoactive drugs to provide cardiovascular support, or renal replacement therapy. All surgical patients in the ICU database were included in the analysis. We used death and hospital discharge records to identify whether patients died during their hospital stay. Intensive care unit stays could not be matched to a hospital discharge summary for 649 of 25 017 patients (2.6%). For these patients, hospital discharge date and status were retrieved from the WardWatcher data set. The nature of hospital admission was unknown for these patients and they were excluded from analysis of admission type (emergency vs elective).
APACHE II scores were not recorded for 5732 patients (22.9%), and the proportion of patients with missing scores was described for both groups. For calculation of the numbers of organs supported, patients were categorized as not having received support for an organ with missing data.
Statistical Analysis
Median and interquartile ranges (IQRs) were used to summarize continuous variables, and Wilcoxon rank sum test was applied to determine differences in median values. Pearson χ 2 test and exact 95% CIs were used to compare proportions.
reason for ICU admission, APACHE II score of 20 or higher (higher scores indicate increased severity of illness and corresponding mortality), and year of group's ICU admission. A multivariate model was then constructed using factors with significance at P < .05, determined using 2-tailed, paired testing on univariate analysis with the exception of reason for ICU admission documented as malignancy, because this diagnosis had colinearity with the presence of cancer. All patients were included in survival analysis. A timevarying covariate indicated the period in ICU, the stay in the hospital following discharge from the ICU, and the period following hospital discharge. Kaplan-Meier curves and log-rank test were used to compare survival between the cancer and noncancer group. Statistical analyses were performed using Stata, version 14.0 (StataCorp).
Results
During the study period, there were 25 017 surgical patients admitted to general ICUs in the West of Scotland, of whom 13 694 (54.7%) were male. The median age was 64 years (IQR, 50-74), and 5462 (21.8%) had an underlying solid tumor diagnosis. Table 1 gives patient characteristics for surgical admissions to ICU with and without a diagnosis of cancer. 
ICU Patients Receiving Organ Support
There were 16 211 surgical patients admitted to the ICU who received organ support during the study period (Table 1) . Of these, 3165 (19.5%) had a solid tumor diagnosis. The APACHE II score was available for 92.0% of ICU patients without cancer (12 006 of 13 046) and 90.7% of ICU patients with cancer (2872 of 3165), and the median (IQR) value was 18 (14-24) and 18 (14-23). Within this group of patients, respiratory support was the most common mode of support for both the cancer and noncancer groups at 92.2% (2919 of 3165 patients) and 94.3% (12 300 of 13 046 patients), respectively. Cardiovascular support was provided to 50.0% of the cancer group (1584 of 3165 patients) and 54.6% of the noncancer group (7103 of 13 046 patients). Data pertaining to provision of renal replacement therapy was missing in 1365 patients without cancer (10.5%) and 301 patients with cancer (9.5%). Renal replacement therapy was not commonly provided in either group, but those patients in the cancer group had a lower prevalence of RRT (237 of 3165 patients [8 
Outcomes of Underlying Tumor Type
Factors Associated With Hospital Mortality
Hospital mortality is described for different admission features in patients with and without cancer in Table 3 . Hospital mortality was lower in the cancer group when categorized by the patient's age, severity of illness, and admission year. Mortality was higher in the cancer group for patients admitted to the hospital electively (14.8%, 95% CI, 13.6%-16.1%; vs 12.8%, 95% CI, 11.7%-13.9%; P = .01) and for patients admitted to the hospital as an emergency (32.7%, 95% CI, 30.7%-34.7%; vs 29.1%, 95% CI, 28.4%-29.9%; P = .001). Odds ratios are reported in Table 4 for factors associated with hospital mortality. The factor with the greatest association with hospital mortality was severity of illness (APACHE II score, ≥20; OR, 4.67; 95% CI, 4.34-5.01) followed by age 65 years or older (OR, 2.14; 95% CI, 2.01-2.29) and emergency hospitalization (OR, 2.86; 95% CI, 2.62-3.12). Admission to the ICU directly from the surgical theater was protective (OR, 0.53; 95% CI, 0.49-0.56).
Patients with cancer had an OR of 1.09 (95% CI, 1.00-1.19) for hospital mortality after adjustment for age, hospitalization type, admission source, sepsis, APACHE II score, and year of ICU admission.
Longer-term Mortality Following ICU Admission
Longer-term survival of surgical ICU patients with and without cancer is demonstrated in the Figure. While the initial mortality associated with the critical illness appears similar, the patients in the cancer group had a higher mortality by 6 months (31.3% vs 28.2%; P < .001). The survival curves continue to diverge and, by 4 years, the mortality of surgical ICU patients with cancer was 60.9% compared with 39.7% seen in the group without cancer.
Discussion
In an unselected, population-based cohort, 1 in 5 surgical patients admitted to the ICU had a cancer diagnosis within 2 years of admission. These patients with cancer appeared to have an initial survival advantage over the noncancer cohort with favorable ICU and hospital mortality rates. Compared with patients without cancer, those with cancer were older and more likely to be admitted to the ICU following elective hospitalization; however, they had similar severity of illness. This finding is in keeping with those of previous studies. 8, 10 Malignancy was the commonest reason for ICU admission in the cancer group. In the noncancer cohort, 1.2% had malignancy recorded for their admission diagnosis. It is possible that this was a diagnostic error in which malignancy was Abbreviations: APACHE, Acute Physiology and Chronic Health Evaluation (higher scores indicate increased severity of illness and corresponding mortality); ICU, intensive care unit; NA, not applicable; OR, odds ratio. a Not included in multivariate model owing to colinearity with cancer.
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Characteristics and Outcomes of Patients With Solid Cancers Admitted to the Intensive Care Unit suspected prior to histologic confirmation. Alternatively, patients with cancer who were not residents of Scotland may have been treated in one of the included ICUs without appearing on the Scottish Cancer Registry. Severity of illness scores for patients with and without cancer were suggestive of a similar burden of acute illness. However, multiorgan support occurred more frequently in the group of patients without cancer. This difference could be due to treatment limitations imposed on cancer patients or a lower frequency of multiorgan failure. The cancer group had a higher proportion of patients without recorded APACHE II scores, which might reflect a "well" cohort of patients admitted only for postoperative observation and therefore excluded from scoring. When the group of patients without organ support was excluded, analysis of patients admitted to the ICU for organ support revealed a similar pattern of APACHE II scores between those with and without cancer, but lower mortality in the cancer group. In both groups, patients admitted to the hospital electively had a favorable mortality compared with those admitted to the ICU after an emergency hospitalization. This finding might be attributable to the opportunity for preoperative optimization and selection of patients without significant comorbidity for intervention. When analyzed by emergency or elective hospitalization type, mortality was higher for patients with cancer compared with the noncancer group. However, mortality for the elective admission cancer group was lower than that in the emergency admission noncancer group. We propose that the large proportion of elective hospitalizations within the cancer group has a significant association with the apparent survival advantage of patients with cancer admitted to the ICU.
After multivariate regression analysis, patients with cancer had only a marginally increased risk (OR, 1.09) of hospital mortality compared with the noncancer population. Factors that had a greater association with mortality were severity of illness, emergency hospitalization, and older age, which all increased the risk of hospital mortality, and admission directly from the surgical theater, which reduced the risk. This finding is consistent with previous studies that suggest that the immediate critical illness has a greater influence on short-term outcomes than the underlying cancer. 6 Intensive care unit and hospital mortality varied considerably by underlying cancer type consistent with that described by Bos and colleagues.
11 Favorable outcomes were seen for patients with thyroid, head and neck, and kidney tumors. In contrast, high ICU and hospital mortality rates were observed in patients with pancreas, lung, and liver cancer for which survival outside the ICU setting is generally poorer compared with other tumor types. Patients with an unknown tumor type had the highest mortality rates demonstrated, although this might reflect a group of patients who died prior to definitive diagnosis or those for whom further investigation would be inappropriate owing to disease burden or severe comorbidities. While clinicians should be aware that not all cancers are equal in terms of survival following surgical ICU admission, mortality rates are such that none of the tumor types should automatically preclude admission.
As more patients with cancer require critical care, clinical judgment needs to be informed by knowledge of outcomes in similar patients. The hospital mortality described for patients with cancer who are admitted to the ICU after elective hospitalization in this study is significantly higher than that described by Bos et al 9 (14.8% vs 4.7%, respectively). However, the study by Bos et al only included patients who had a planned admission to the ICU. In comparison, patients in the present study may have had a planned admission to the hospital but required admission to the ICU only after an unexpected complication. In the same setting, surgical patients with an unplanned admission to the ICU had a hospital mortality of 17.4%, 10 which is nearly half of that described in this study.
This low mortality may be explained by the lower use of organ support in the study by Bos et al and the inclusion of patients undergoing elective surgery but admitted as an emergency after a complication. These differences highlight the importance of reporting a comparator group within the same study population to allow any real differences to be appreciated. While immediate outcomes in this study may favor the group with cancer, this advantage was reversed by 6 months and survival thereafter was poorer in the group of patients with an underlying tumor. By 4 years, the difference in survival was 39.1% compared with 60.3% for surgical ICU patients with and without cancer. To our knowledge, no previous study has described longer-term survival for ICU patients with cancer compared with those without cancer to this degree. It has been established in the literature that short-term outcomes are related to the critical illness rather than the underlying tumor, 6 and it seems likely that as patients recover from their critical illness, comorbidities such as cancer have an increasing association with survival in the longer term.
Strengths and Limitations
A strength of this study is that it presents the characteristics of patients with cancer admitted to nonspecialized ICUs from There was a statistically significant difference in survival by log-rank test (P < .001).
Characteristics a surgical population. The type of cancer was verified from cancer registration data. Our findings therefore are representative of practice in general hospitals and suitable for generalization. However, it is probable that APACHE II scores and organ support that were not recorded are not missing at random 13 and might depend on the severity of illness, the admitting ICU, and whether the patient died during the ICU stay. Odds ratios demonstrated a slight increase in hospital mortality in patients without an APACHE II score recorded (OR, 1.46) and the reason for this is unknown. This group of patients with unrecorded APACHE II scores is likely to be a mix of those who were excluded from scoring because of a high-dependency unit admission (in which survival would be expected to be favorable) and those who died before full scoring was possible. Owing to the retrospective design of this study, we do not know the exact reason for this finding. A further limitation of this study is that our analysis was restricted to the information already collected and we were therefore unable to report on specifics, such as performance status or tumor stage, both of which are known to have a significant association with survival.
Conclusions
We found that cancer is a common condition present in surgical patients admitted to the ICU. Patients with cancer were more likely to have been admitted to the hospital electively and receive no organ support in the ICU. Short-term outcomes in patients with cancer admitted to the ICU varied significantly by underlying tumor type, severity of illness, and admission features. Contrary to previous studies, ICU patients with cancer had favorable short-term outcomes compared with ICU patients without cancer, although this survival advantage had disappeared by 6 months. After adjusting for other prognostic variables, ICU patients with cancer did not have a meaningful increase in their risk of hospital mortality compared with patients without cancer. In view of these findings a diagnosis of cancer should not preclude admission to an ICU in surgical patients. To be able to better inform admission decisions, further work is needed on individual cancers to determine which features have prognostic value.
